Does an IV glutathione drip lighten your skin?
No. There is no good published evidence that intravenous glutathione lightens or brightens skin tone, and no injectable product is approved in the United States for that purpose. The FDA has called injectable skin whitening and bleaching products potentially unsafe and ineffective. If a med spa is selling you an infusion on the promise of a lighter complexion, that is a marketing claim, not a clinical one.
Two statements sound similar here and are not. "There is no good evidence this works" is different from "this has been proven not to work." The honest position is the first one. The research is thin enough that nobody can tell you with confidence what an infusion will do to your skin tone, and a business charging $399 for the bag should say so out loud.
We run a glutathione drip. We do not sell it as a skin-lightening treatment, and the rest of this page explains why.
Has the FDA approved glutathione injections for skin lightening?
No. The FDA has not approved any injectable drug for skin whitening or lightening, and it has told consumers that these products are unapproved new drugs that may contain unknown harmful ingredients or contaminants, and that improper or unsafe injection practices may transmit disease, cause infection and result in serious injury.
The agency has backed that up with enforcement. On September 25, 2017 a federal judge ordered a New Jersey company, Flawless Beauty LLC, to halt sales and recall products, and in January 2018 the company recalled nineteen products the FDA alleged were misbranded or unapproved new drugs. Eleven of the seventeen line items on that notice are injectable glutathione whitening kits, sold under names like Relumins, Tatiomax, Tationil and Saluta. The other six are the vitamin C ampules, sterile water, human placenta vials and capsules sold alongside them.
Glutathione is available in the US as a compounded preparation that a licensed provider can order for a patient. Compounding is a legal pathway, not an FDA finding that a drug is safe and effective. A compounded vial is not an approved skin-lightening product, and no one should present it as one.
What does the research actually show about IV glutathione and skin tone?
Very little, and what exists is small, short and low quality. A 2018 review in Dermatology Practical & Conceptual found the clinical evidence for intravenous glutathione as a skin-lightening agent was limited to a single study with what the authors called a dubious study design and apparently flawed analysis. That is the entire intravenous evidence base those reviewers could find.
A 2025 narrative review in Cureus landed in a similar place. In the one placebo-controlled intravenous trial it describes, the lightening participants reported had faded by six months, and the reviewers concluded that large, well-designed clinical trials are still needed to answer long-term safety, optimal dosing and durability.
There is also no standardized dosing protocol for the intravenous route. The doses in the published work were chosen by investigators, not set by any guideline: that trial used 1,200 mg twice a week for six weeks, while the patients in the FDA's 2019 compounding alert had received single doses of 1,400 mg and 2,400 mg. When the dose is that unsettled, "how much is too much" does not have a published answer.
What is glutathione, and what does it actually do in the body?
Glutathione is a tripeptide your body makes for itself, built from three amino acids, produced inside your cells and central to how cells handle oxidative stress. Around 90 percent of it sits in the cytosol, and its production is tightly regulated at several levels.
That is real physiology. It is also a long way from a visible change in the color of your face. Antioxidant activity in a cell and a measurable shift in skin tone are two different outcomes, and the second does not follow from the first. Skin color comes from melanin, whose production is influenced by genetics, sun exposure, hormones and inflammation — a system a bag of fluid does not simply override.
Is IV glutathione safe?
Not for cosmetic use — that has never been established, and the published literature documents serious harm from the drug itself, not only from bad product. The 2025 Cureus review states that intravenous glutathione raises serious safety concerns including the risk of anaphylaxis and hepatotoxicity, compounded by the lack of standardized protocols. In the single placebo-controlled intravenous trial that review describes, 32 percent of participants had adverse events, including liver dysfunction and one case of anaphylaxis.
Those are not minor reactions. Anaphylaxis is a life-threatening allergic emergency. Hepatotoxicity means liver injury. The reviewers' own recommendation is that the injectable form be restricted to closely supervised clinical settings, and the Philippine Food and Drug Administration has issued warnings against IV glutathione citing liver damage, severe allergic reactions and the absence of standardized dosing protocols.
Separate from the drug itself, any infusion carries the ordinary risks of putting a catheter in a vein: bruising, infiltration, phlebitis, infection, allergic reaction, and fluid overload in people with heart or kidney disease. We cover those on our safety page, and there is a real list of people who should not get a drip at all on who should skip a drip.
We are not going to describe IV glutathione as well tolerated. Its own literature says otherwise. When the documented risks include anaphylaxis and liver injury, and the expected benefit for a cosmetic goal is unestablished, the trade is hard to justify.
Why does it matter where the glutathione came from?
Contaminated raw material has caused the best-documented clusters of injury from IV glutathione, and it is the one variable a provider fully controls. That risk sits on top of the risks of the drug itself. Clean sourcing does not turn an unestablished cosmetic treatment into a safe one; it removes one avoidable way to get hurt.
In February 2019 the FDA warned compounders not to use a glutathione powder labeled "Caution: Dietary Supplement" to make sterile injectable drugs. Seven patients at one outpatient clinic had each received 1,400 mg of IV glutathione compounded from that material and, within minutes, developed nausea, vomiting, lightheadedness, chills, body aches and sneezing. One developed low blood pressure and difficulty breathing and was transferred to a hospital. A second report involved a patient admitted for a possible bloodstream infection. FDA's laboratory found bacterial endotoxin in the powder, with some results as high as five times the appropriate limit.
It was not isolated. Seven probable endotoxin poisonings from compounded glutathione infusions were documented in Sydney, Australia in 2015. The index patient was a 41-year-old woman who fell ill fifteen minutes into her infusion with a fever of 39.5 °C and a blood pressure of 79/47, presented to an emergency department looking like bacterial sepsis, stayed hypotensive despite four liters of saline, and was treated with broad-spectrum antibiotics despite negative cultures. She later developed Clostridium difficile diarrhea as a likely complication.
And it is not history. In August 2026 two Texas compounding pharmacies recalled compounded glutathione 200 mg/mL vials nationwide, two weeks apart, both for elevated bacterial endotoxin: Victory Medical Center Pharmacy of Austin on August 5 and Optimal Balance Pharmacy of Houston on August 19. Both had already received reports of fever, chills, severe headache, nausea, vomiting and pain.
So the questions worth asking any provider are these: Which licensed pharmacy compounded this vial? Was the raw material manufactured for sterile injection, or is it supplement-grade powder? Is it within date, and has that pharmacy had recalls? A provider who cannot answer is guessing on your behalf.
Is oral or topical glutathione any better?
Not in a way that changes the answer for IV, though the safety picture is better. The 2025 Cureus review reports that oral glutathione has shown measurable but sometimes inconsistent lightening effects with a favorable safety profile at standard doses, and that topical formulations had minimal, self-resolving side effects — while still calling for the large, well-designed trials that have not been done. No oral or topical glutathione product is FDA-approved for lightening skin either.
FDA-approved prescription topical drug products do exist for pigmentation conditions such as melasma and hyperpigmentation. It is also worth knowing that over-the-counter skin lightening products containing hydroquinone or mercury are illegal to sell in the US — hydroquinone is available by prescription, and mercury in these products is banned outright.
Why do we still offer a glutathione drip if it doesn't lighten skin?
Because a glutathione drip and a skin-lightening treatment are not the same product, and we only sell the first one. Glutathione appears as a component of two infusions, The Glow and The Beauty, and as a standalone vitamin injection — as an antioxidant, administered by a registered nurse under a licensed provider's order, using product sourced from licensed US pharmacies. That is the whole of what we claim.
We are not going to call our own drip well tolerated either. The risks in the safety section above apply to it, and they are the reason a licensed provider has to clear you before a nurse starts anything.
Here is what is reasonable to expect from a drip visit: a liter of fluid, a vitamin C and B-complex load, an hour lying down, and hydration you would otherwise be chasing with a water bottle. That much is real.
Here is what is not: a lighter, whiter or brighter complexion. If that is what you are hoping to buy, we would rather you kept your money. Anyone promising dramatic tone change from an infusion is overselling.
What should you do if you want your skin tone to change?
Start with a board-certified dermatologist rather than an IV menu. Pigmentation has causes — melasma, post-inflammatory hyperpigmentation, sun damage, hormonal shifts — and the approved treatments are matched to the cause. A dermatologist can tell you which one you have. An IV nurse cannot, and should not pretend otherwise.
If you want a glutathione drip for the reasons it is actually reasonable to want one, here is who decides. California law requires a good-faith exam by a physician, nurse practitioner or physician assistant and a patient-specific order before administration; the RN administers but cannot order (Business & Professions Code § 2725.1). A licensed provider examines you and writes the order; your RN then reviews your history, medications and allergies at the bedside before starting anything. There are days when the right answer from either of them is that you skip it.
You can see the full menu and pricing, read how IV therapy works, or ask us a question first. And if you have already had injectable skin lightening products and felt unwell afterward, see a doctor. Reactions to contaminated product can begin within minutes of the infusion and are worth taking seriously.
- U.S. Food and Drug Administration (archived FDA consumer update, content current as of 04/19/2018; the live fda.gov English URL returns 404, verified by direct request) — The FDA has not approved any injectable drugs for skin whitening or lightening; these products are potentially unsafe and ineffective and might contain unknown harmful ingredients or contaminants; improper or unsafe injection practices may transmit disease, cause infection, and result in serious injury. On September 25, 2017 a federal judge ordered Flawless Beauty LLC of New Jersey to halt sales and recall products; FDA-approved topical drug products exist for conditions such as hyperpigmentation and melasma.
- U.S. Food and Drug Administration — Under a Consent Decree of Permanent Injunction ordered in the U.S. District Court for the District of New Jersey, Flawless Beauty, LLC voluntarily recalled all lots of nineteen different products alleged by FDA to be misbranded or unapproved new drugs, announced January 18, 2018. Seventeen line items are published on the recall notice. Eleven are injectable glutathione whitening kits: Relumins Advanced Glutathione kits with 900 mg, 1500 mg and 3000 vials; Tatiomax Glutathione Whitening kits w/ 1400mg vials; Saluta Glutathione Whitening kits with 600 mg, 1200 mg and 1800 mg vials; Tationil Glutathione Whitening 10 vial kits; Tationil Glutathione Whitening (5 sets of 10 vial kits); Reiki Glutathione Whitening kits; and TAD Glutathione Whitening kits w/ 600mg vials. The other six are Relumins Vitamin C Solvent ampules, Laroscorbine Platinum Vitamin C with Collagen 1100mg, Laennec Human Placenta Whitening kits 2ml vials, TP Drug Laboratories Vitamin C ampules, Sterile water ampules, and Ling Zhi capsules. The page states that all glutathione products were sold in multi-vial whitening kits, either alone or in combination with ampules of vitamin C and sterile water.
- U.S. Food and Drug Administration — FDA warned compounders on February 1, 2019 not to use L-glutathione powder labeled “Caution: Dietary Supplement” to compound sterile injectable drugs. Seven patients at an outpatient clinic each received 7 mL (1,400 mg) of L-glutathione 200 mg/mL by injection on January 9, 2019 and within minutes experienced nausea, vomiting, lightheadedness, chills, body aches and sneezing; one experienced low blood pressure and difficulty breathing and was transferred to a hospital. A second report involved a patient who received 12 mL (2,400 mg) and was admitted to the hospital for a possible bloodstream infection. All samples tested by an FDA laboratory contained excessive bacterial endotoxin, with some results as high as five times the appropriate limit.
- U.S. Food and Drug Administration — On August 5, 2026, Victory Medical Center Pharmacy of Austin, Texas voluntarily recalled certain lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials nationwide to the patient level due to elevated bacterial endotoxin levels, having received reports of adverse events including fever, chills, severe headache, nausea, vomiting, tachycardia, changes in blood pressure, body aches and injection site reactions.
- U.S. Food and Drug Administration — On August 19, 2026, Optimal Balance Pharmacy of Houston, Texas voluntarily recalled one lot of Compounded Glutathione 200 mg/mL 30 mL Multi-Dose Vials nationwide to the patient level due to elevated bacterial endotoxin levels, having received reports of adverse events including fever, chills, severe headache, nausea, vomiting, pain, and symptoms consistent with an allergic reaction.
- Sonthalia S, Jha AK, Lallas A, Jain G, Jhakar D. Dermatology Practical & Conceptual, 2018;8(1):15-21 — Parenteral glutathione is approved only for severe liver disorders and prevention of chemotherapy-associated neurotoxicity; the current clinical evidence of intravenous glutathione for skin lightening is limited to a single study with a dubious study design and apparently flawed analysis of results.
- Alzahrani TF et al. Cureus, 2025;17(1):e78045 — Intravenous glutathione raises serious safety concerns, including the risk of anaphylaxis and hepatotoxicity, compounded by the lack of standardized protocols and rigorous clinical studies; the injectable form should be restricted to closely supervised clinical settings. In the placebo-controlled intravenous trial described, participants received 1200 mg IV twice a week for six weeks, the reported effects faded after six months, and 32% of participants experienced adverse events including liver dysfunction and one case of anaphylaxis. The Philippine Food and Drug Administration has issued warnings against IV glutathione citing liver damage, severe allergic reactions, and the absence of standardized dosing protocols. Oral supplementation has shown measurable, though sometimes inconsistent, skin-lightening effects and a favorable safety profile at standard dose levels; topical formulations were associated with minimal and self-resolving side effects. Additional large, well-designed clinical trials are needed to address long-term safety, optimal dosing, and the durability of any skin-lightening effect.
- Johnstone T et al. Epidemiology and Infection, 2018;146(7):931-934 — Seven cases of probable endotoxin poisoning were linked to contaminated compounded glutathione infusions in Sydney, New South Wales in February 2015. The index case was a 41-year-old female patient who presented to an emergency department with symptoms consistent with bacterial sepsis, having felt ill 15 minutes into infusion administration with fever (39.5 °C), hypotension (BP 79/47), muscle twitches, vomiting, diarrhoea and abdominal, neck and back pain; the hypotension persisted despite administration of 4 L normal saline; blood and urine cultures were negative but she was treated with broad-spectrum antimicrobial therapy, and she developed Clostridium difficile associated diarrhoea on day 17, a likely complication of hospitalisation and administration of broad-spectrum antibiotics. Endotoxin testing of unused vials and powder revealed levels exceeding the internationally accepted maximum pyrogenic threshold of 5 endotoxin units/kg/h.
- Aquilano K, Baldelli S, Ciriolo MR. Frontiers in Pharmacology, 2014;5:196 — Glutathione is the tripeptide gamma-L-glutamyl-L-cysteinyl-glycine, synthesized intracellularly by two ATP-dependent enzymes, with the majority (almost 90%) in the cytosol, and its metabolism is controlled at transcriptional, translational and post-translational levels.
- U.S. Food and Drug Administration — Melanin is the pigment responsible for skin color. The over-the-counter sale of skin lightening products containing hydroquinone or mercury is illegal in the US; hydroquinone skin products are available by prescription from a health care provider, and the use of mercury in skin lightening products is banned.